U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07181265) titled 'Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects' on Sept. 12.
Brief Summary: This is a open-label, non-randomized, multiple oral dosings, three-period, drug-drug interaction study of JMKX003142 tablet, Amiodarone Hydrochloride Tablets and Febuxostat Tablets in Chinese healthy adult subjects
Study Start Date: Oct. 30
Study Type: INTERVENTIONAL
Condition:
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Intervention:
DRUG: Amiodarone Hydrochloride Tablets
Cohort 1: The intervention is for study of drug drug interaction of JMKX003142 when administered with Amiodarone
DRUG: Febuxostat ...